Article2018-02-06T17:27:34+00:00

PHE's Huber Leads New Study on Social, Economic Impacts of 2014 Ebola Crisis

Led by Caroline Huber, Associate Director of Policy and Economics, a surprising new study was recently published in The Journal of Infectious Diseases, estimating the overlooked social, economic and health impacts of the 2013-2016 West Africa Ebola crisis.

Along with her colleagues, Dr. Huber estimated that overall costs of the Ebola outbreak totaled more than $53 billion, exceeding previous estimates by more than $20 billion. Factoring in deaths from non-Ebola causes during this period, the study provides valuable new data on the overall impact of the crisis and identified specific costs missed by other accountings to determine the overall global costs of the unprecedented outbreak.

The study’s release has generated a significant amount of media interest, with coverage appearing in numerous outlets including Reuters and the BBC, who interviewed Dr. Huber as part of their Newsday radio program.

To read more about the study and the findings of Dr. Huber and her research team, read the complete article:  The Economic and Social Burden of the 2014 Ebola Outbreak in West Africa.

In addition, a concise summary of the study can be found on the Science Speaks blog.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.

OK